NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying Its Position as the Leader in MedTech Testing and Clinical Research
NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announces that it has entered into a definitive agreement to acquire the U.S. medical device testing operations of WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable the pharmaceutical and life science industries to advance discoveries and […]